Ferguson J, MacDonald K J, Kenicer K J
Br J Clin Pharmacol. 1985 Dec;20(6):639-41. doi: 10.1111/j.1365-2125.1985.tb05122.x.
Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial. An oral twice daily 60 mg dose of terfenadine was given and itch and wheal parameters were assessed daily. Despite the overall effectiveness of terfenadine, a variable response was noted which was similar to that shown in previous studies with other antihistamines.
特非那定是一种强效非镇静性抗组胺药,在一项双盲交叉安慰剂对照试验中显示对慢性特发性荨麻疹有效。给予每日两次口服60毫克特非那定的剂量,并每天评估瘙痒和风团参数。尽管特非那定总体有效,但仍观察到个体反应存在差异,这与先前使用其他抗组胺药的研究结果相似。